NASDAQ: TGTX · Biotechnology
Over the past week, TG Therapeutics (TGTX) racked up about 39 mentions across Reddit, X and news, and the read is an Adanos Buy. The crowd averages 78% bullish but is sharply divided: News runs 100% bullish while X sits at just 66%. Wall Street is more constructive, with 7 of 8 analysts rating TGTX a buy.
There is little buzz around TGTX this week and little agreement on direction, which is why it reads as a Buy.
Wall Street’s 88% buy share sits next to a crowd that ranges from X at 66% to News at 100%. No other tracker puts the two side by side.
8 analysts have weighed in: a Strong Buy consensus: 7 buy calls against 1 sell, with an average 12-month price target of $69.71.
The Adanos signal blends each source’s bullish ratio, source breadth, buzz intensity and 3-day momentum. This week bullish sits above the neutral line, momentum is cooling and the 3 sources disagree sharply, so the read is a Buy.
Analysts sit 10 points above the crowd average of 78%, the professionals are more constructive than retail. The split is inside the crowd: News reads 100% bullish while X sits at 66%, a 34-point spread that single-source trackers miss.
Over the 30-day window, TG Therapeutics (TGTX) buzz held subdued around 33.3 while the price drifted up 6.5% across the period. The chart tracks how social and news attention moved against end-of-day price. Average daily trading volume across the displayed trading days is 1.8M shares. Updated Sep 26, 2026. Over the last 7 trading days, TGTX gained 1.7%. Buzz activity in the recent week averaged 43.8 and was variable, swinging between 31.9 and 68.5. Recent volume is running above the 30-day average, suggesting heightened trading interest. Daily crowd sentiment leaned bullish on 15 of the 18 days with directional mentions, shown as the green, grey and red breakdown bars below the chart.
Signal metrics use the latest 7 days; contributor and breadth context uses the 30-day chart window.
No Polymarket data for this stock this week.
Query sentiment for TGTX and 2110+ stocks from your terminal. Filter by source, timeframe and signal strength.
View CLIEmbed live TGTX sentiment on your own site with drop-in web components.
View WidgetsThis week’s sentiment from Adanos, with fundamentals and analyst consensus. A quick-reference snapshot for Sep 26, 2026.
| Adanos signal | Buy |
|---|---|
| Analyst consensus | Strong Buy (7 / 0 / 1) |
| Crowd bullish (7d) | 78% |
| Avg price target | $69.71 |
| Most bullish source | News, 100% |
| Most bearish source | X, 66% |
| Sentiment spread | 34 pts |
| Mentions (7d) | 39 |
| Market cap | $8.81B |
| P/E · Forward P/E | 20.5 · 25.9 |
| EPS · Beta | $2.81 · 1.7 |
| Revenue (TTM) | $799.5M · 55% margin |
| Industry | Biotechnology |
Based on aggregated sentiment from Reddit, X and News sources, TG Therapeutics (TGTX) currently carries an Adanos buy signal with 93/100 conviction. The current cross-source average reads 78% bullish across 3 active sources. Those sources contribute 39 tracked mentions over the last 7 days. This is a sentiment-based reading, not financial advice.
Reddit discussion around TG Therapeutics (TGTX) is fairly quiet with 3 mentions over the last 7 days; the 30-day context spans 4 tracked subreddits. The 7-day tone is 67% bullish; 3-day activity momentum is falling, suggesting cooling attention.
The crowd reads bullish on TG Therapeutics (TGTX), averaging 78% bullish across 3 tracked sources over the last 7 days. The two ends of the range are News at 100% bullish and X at 66%, a 34-point spread. On the professional side, 7 of 8 analysts rate TGTX a buy.
Of the 8 analysts covering TG Therapeutics (TGTX), 7 rate it a buy, 0 a hold and 1 a sell, for a strong buy consensus. The average price target is $69.71. That puts the street ahead of the crowd, which averages 78% bullish.
TG Therapeutics (TGTX)'s cross-source average is bullish at 78% bullish. All 3 tracked sources lean bullish. Reddit reads 67% bullish, News reads 100% bullish and x coverage is the most negative at 66% bullish. The combined signal points to broad buy-side pressure with 93/100 conviction.
The cross-source average is bullish for TG Therapeutics (TGTX) at 78% bullish. All 3 tracked sources lean bullish. The most bearish reading is x at 66% bullish. 3-day activity momentum is falling across Reddit and X. The buy signal carries 93/100 conviction.
X is the dominant discussion channel with 35 mentions (90% of total volume). Reddit contributes 3 mentions and News contributes 1 mention. The cross-source average is bullish at 78% bullish. All 3 tracked sources lean bullish.
The Adanos signal blends bullish ratio, buzz score, source breadth and 3-day activity momentum into a single buy/sell reading. TGTX's buy signal at 93/100 conviction reflects a bullish cross-source average at 78% bullish. All 3 tracked sources lean bullish. It is a research shortcut, not financial advice.
The TGTX sentiment page is regenerated from the latest 7-day tracking window at each build. Data reflects the most recent Reddit posts, tweets and news articles available in the current publishing cycle.
Peers are ranked first by matching the Buy signal, then by the closest bullish ratio. Discussion activity breaks any remaining ties.
Every data point on this page comes from the Adanos sentiment APIs. Get a free API key and start querying Reddit, X, News and Polymarket sentiment programmatically.
Get Free API Key